Liquid Biopsies in Patients With Advanced Non-small Cell Lung Cancer
Status: Recruiting
Location: See all (8) locations...
Study Type: Observational
SUMMARY
The goal of this project is to characterize the genetic profile of patients with advanced stage IIIB/IV non-small cell lung cancer (NSCLC) using liquid biopsies
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients with histologically confirmed advanced non-small-cell lung carcinoma (stage IIIB/IV) regardless of the mutation status
• Inclusion at the time of diagnostic
• Realization of tumor biopsy at the institution (Centre Léon Bérard) or outside the institution with an available histopathological report
• Age ≥ 18 years
• Covered by a health insurance
• Signed consent
Locations
Other Locations
France
Centre Hospitalier Annecy Genevois
ACTIVE_NOT_RECRUITING
Annecy
CH Fleyriat
ACTIVE_NOT_RECRUITING
Bourg-en-bresse
Hôpital Louis Pradel
ACTIVE_NOT_RECRUITING
Bron
CHU Grenoble Alpes
ACTIVE_NOT_RECRUITING
Grenoble
Centre Léon Bérard
RECRUITING
Lyon
CHRU de Saint-Etienne
ACTIVE_NOT_RECRUITING
Saint-priest-en-jarez
Institut de Cancérologie Lucien Neuwirth
ACTIVE_NOT_RECRUITING
Saint-priest-en-jarez
Hôpital Nord Ouest
ACTIVE_NOT_RECRUITING
Villefranche-sur-saône
Contact Information
Primary
Pierre Saintigny, MD, PhD
pierre.saintigny@lyon.unicancer.fr
Time Frame
Start Date: 2015-07
Estimated Completion Date: 2026-12
Participants
Target number of participants: 900
Treatments
Cohort 1
Patients with advanced NSCLC and no druggable molecular alteration at time of diagnosis
Cohort 2
Patients with advanced NSCLC harboring targetable molecular alterations at time of diagnosis
Cohort 3
Patients with advanced NSCLC at time of immunotherapy introduction (1st or 2nd line)
Related Therapeutic Areas
Sponsors
Leads: Centre Leon Berard